4.6 Review Book Chapter

Adverse Effects of Nutraceuticals and Dietary Supplements

Journal

Publisher

ANNUAL REVIEWS
DOI: 10.1146/annurev-pharmtox-010617-052844

Keywords

toxicity; multivitamin; multimineral; soy protein isolate; isoflavones; bodybuilding supplements; herb-drug interaction

Funding

  1. NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R37AA009300, R37AA018282] Funding Source: NIH RePORTER
  2. NIAAA NIH HHS [R01 AA018282, R37 AA018282, R37 AA009300] Funding Source: Medline

Ask authors/readers for more resources

Over 70% of Americans take some form of dietary supplement every day, and the supplement industry is currently big business, with a gross of over $28 billion. However, unlike either foods or drugs, supplements do not need to be registered or approved by the US Food and Drug Administration (FDA) prior to production or sales. Under the Dietary Supplement Health and Education Act of 1994, the FDA is restricted to adverse report monitoring postmarketing. Despite widespread consumption, there is limited evidence of health benefits related to nutraceutical or supplement use in well-nourished adults. In contrast, a small number of these products have the potential to produce significant toxicity. In addition, patients often do not disclose supplement use to their physicians. Therefore, the risk of adverse drug-supplement interactions is significant. An overview of the major supplement and nutraceutical classes is presented here, together with known toxic effects and the potential for drug interactions.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available